74
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Positive correlation of airway resistance and serum asymmetric dimethylarginine level in COPD patients with systemic markers of low-grade inflammation

, , , , , , , , & show all
Pages 873-884 | Published online: 14 Mar 2017

References

  • MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
  • LoddenkemperRGibsonGJSibilleYEuropean Respiratory SocietyEuropean Lung Foundation European Lung White Book: The First Comprehensive Survey on Respiratory Health in EuropeSheffieldEuropean Respiratory Society2003
  • AydinMAltintasNCem MutluLAsymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPDClin Respir J Epub2015616
  • CostanzoLPedoneCBattistoniFChiurcoDSantangeloSAntonelli-IncalziRRelationship between FEV1 and arterial stiffness in elderly people with chronic obstructive pulmonary diseaseAging Clin Exp Res Epub2016321
  • BarnesPJCellular and molecular mechanisms of chronic obstructive pulmonary diseaseClin Chest Med2014351718624507838
  • RuzsicsINagyLKekiSL-arginine pathway in COPD patients with acute exacerbation: a new potential biomarkerCOPD201613213914526514682
  • PeraTZuidhofABSmitMArginase inhibition prevents inflammation and remodeling in a guinea pig model of chronic obstructive pulmonary diseaseJ Pharmacol Exp Ther2014349222923824563530
  • ScottJADuonghMYoungAWSubbaraoPGauvreauGMGrasemannHAsymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD)Int J Mol Sci20141546062607124727374
  • GielisJFLinJYWinglerKVan SchilPESchmidtHHMoensALPathogenetic role of eNOS uncoupling in cardiopulmonary disordersFree Radic Biol Med201150776577621172428
  • RitzTTruebaAFAirway nitric oxide and psychological processes in asthma and health: a reviewAnn Allergy Asthma Immunol2014112430230824428973
  • WellsSMHolianAAsymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cellsAm J Respir Cell Mol Biol200736552052817158357
  • AhmadTMabalirajanUGhoshBAgrawalAAltered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungsAm J Respir Cell Mol Biol20104213819648472
  • KleinEWeigelJBufordMCHolianAWellsSMAsymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthmaAm J Physiol Lung Cell Mol Physiol20102996L816L82520889675
  • WellsSMBufordMCMigliaccioCTHolianAElevated asymmetric dimethylarginine alters lung function and induces collagen deposition in miceAm J Respir Cell Mol Biol200940217918818703795
  • ReczkowskiRSAshDERat liver arginase: kinetic mechanism, alternate substrates, and inhibitorsArch Biochem Biophys1994312131378031143
  • von ElmEAltmanDGEggerMThe Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesPrev Med200745424725117950122
  • KollégiumTSAz Egészségügyi Minisztérium szakmai irányelve a krónikus obstruktiv légúti betegség (chronic obstructive pulmonary disease – COPD) diagnosztikájáról és kezeléséről (1. módosított változat) [Clinical practice guidelines of the Ministry of Health on diagnosis and management of chronic obstructive pulmonary disease (COPD) (first modified version)]Magyar Közlöny20092136613692 Hungarian
  • VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • CelliBRMacNeeWATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
  • SwanneyMPRuppelGEnrightPLUsing the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstructionThorax200863121046105118786983
  • NathellLNathellMMalmbergPLarssonKCOPD diagnosis related to different guidelines and spirometry techniquesRespir Res200788918053200
  • TopalovicMDeromEOsadnikCRTroostersTDecramerMJanssensWBelgian Pulmonary Function Study InvestigatorsAirways resistance and specific conductance for the diagnosis of obstructive airways diseasesRespir Res2015168826194099
  • MeguroMBarleyEASpencerSJonesPWDevelopment and validation of an improved, COPD-specific version of the St George Respiratory QuestionnaireChest2007132245646317646240
  • MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardisation of spirometryEur Respir J200526231933816055882
  • WangerJClausenJLCoatesAStandardisation of the measurement of lung volumesEur Respir J200526351152216135736
  • ZsugaJTorokJMagyarMTSerum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosisCerebrovasc Dis2007235–638839417406107
  • ZsugaJTörökJMagyarMTDimethylarginines at the crossroad of insulin resistance and atherosclerosisMetabolism200756339439917292729
  • JonesPWQuirkFHBaveystockCMThe St George’s respiratory questionnaireRespir Med199185Suppl B2531 discussion 33–371759018
  • JonesPWSt George’s respiratory questionnaire: MCIDCOPD200521757917136966
  • ContoliMBousquetJFabbriLThe small airways and distal lung compartment in asthma and COPD: a time for reappraisalAllergy201065214115119909298
  • WindgassenEBFuntowiczLLunsfordTNHarrisLAMulvaghSLC-reactive protein and high-sensitivity C-reactive protein: an update for cliniciansPostgrad Med20111231114119
  • ManSFConnettJEAnthonisenNRWiseRATashkinDPSinDDC-reactive protein and mortality in mild to moderate chronic obstructive pulmonary diseaseThorax2006611084985316738034
  • HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med2004350262645265315215480
  • SturtonGPerssonCBarnesPJSmall airways: an important but neglected target in the treatment of obstructive airway diseasesTrends Pharmacol Sci200829734034518514920
  • FerrerMVillasanteCAlonsoJInterpretation of quality of life scores from the St George’s Respiratory QuestionnaireEur Respir J200219340541311936515
  • StojkovicJStevcevskaGQuality of life, forced expiratory volume in one second and body mass index in patients with COPD, during therapy for controlling the diseasePrilozi200930112914219736536
  • MaziakWLoukidesSCulpittSSullivanPKharitonovSABarnesPJExhaled nitric oxide in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981573 Pt 199810029517624
  • NuralSGünayEHaliciBCelikSÜnlüMInflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndromeInflammation2013361667422886310
  • ZakrzewiczDEickelbergOFrom arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseasesBMC Pulm Med20099519178698
  • ChungKFCytokines in chronic obstructive pulmonary diseaseEur Respir J Suppl20013450s59s12392035
  • RicciardoloFLNijkampFPFolkertsGNitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary diseaseCurr Drug Targets20067672173516787174
  • HartLAKrishnanVLAdcockIMBarnesPJChungKFActivation and localization of transcription factor, nuclear factor-kappaB, in asthmaAm J Respir Crit Care Med19981585 Pt 1158515929817712
  • SankaralingamSXuHDavidgeSTArginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsiaCardiovasc Res201085119420319684035
  • ChandraSRomeroMJShatanawiAAlkilanyAMCaldwellRBCaldwellRWOxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathwayBr J Pharmacol2012165250651921740411